Visits: 1514, Avg visit time (secs): 215,29 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 468 | 30,91% | |
| /recipients.html | 175 | 11,56% |
| /novartis/efsd-novartis-recipients.html | 149 | 9,84% |
| /msd/efsd-msd-recipients.html | 76 | 5,02% |
| /lilly/efsd-lilly-recipients.html | 52 | 3,43% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-cvd-recipients.html | 49 | 3,24% |
| /gsk/efsd-gsk-recipients.html | 41 | 2,71% |
| /lifescan/efsd-lifescan-recipients.html | 39 | 2,58% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 38 | 2,51% |
| /efsd-grant/efsd-clinres-recipients.html | 38 | 2,51% |
| /bms/efsd-bms-recipients.html | 27 | 1,78% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 560 | 36,99% |
| /gsk/efsd-gsk-recipients.html | 159 | 10,50% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 56 | 3,70% |
| /novartis/efsd-novartis-recipients.html | 40 | 2,64% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-cvd-recipients.html | 40 | 2,64% |
| /efsd-grant/efsd-clinres-recipients.html | 38 | 2,51% |
| /reports.html | 34 | 2,25% |
| /lifescan/efsd-lifescan-recipients.html | 34 | 2,25% |
| /lilly/efsd-lilly-recipients.html | 33 | 2,18% |
| /home.html | 32 | 2,11% |
| /programmes.html | 31 | 2,05% |